Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Sprott Uranium Miners ETF (URNM) Slides -17% Over 30 Days, Down -35% for the Quarter

Sprott Uranium Miners ETF (URNM) Slides -17% Over 30 Days, Down -35% for the Quarter

Key Takeaways

  • Sprott Uranium Miners ETF (URNM) has declined roughly 17% over the past 30 days, extending a multi-month pullback from its late-summer peak.
  • The move follows a sharp rally that carried the fund near $61 per share in late August, before sustained profit-taking took hold.
  • Over the last quarter, URNM is down approximately 35%, reflecting a broad reversal across uranium miners and physical uranium vehicles.
  • Largest holdings such as CCJ, NXE, and UEC have accounted for much of the fund's volatility.
  • Supply-side headlines, including higher output guidance from Kazakhstan's Kazatomprom, have weighed on near-term uranium sentiment.
  • For additional context on valuation, explore Price Targets and Forecast pages for URNM.
  • Discover AI-driven trading ideas and sector signals on Trending AI Robots.

Understanding Sprott Uranium Miners ETF (URNM) and Its Portfolio

Sprott Uranium Miners ETF (URNM) is a passively managed, index-tracking fund that provides exposure to companies engaged in the uranium mining and nuclear fuel cycle. The fund seeks to track the North Shore Global Uranium Mining Index, which includes producers, developers, explorers, and physical uranium vehicles. Because the index permits holdings in physical uranium trusts, URNM carries both equity risk and direct commodity-price sensitivity.

The fund holds roughly two dozen securities, with a portfolio heavily concentrated in the energy sector. The largest positions are Cameco Corporation, the Sprott Physical Uranium Trust, and NexGen Energy, followed by names such as Paladin Energy, Uranium Energy, Kazatomprom, Denison Mines, Energy Fuels, CGN Mining, and Deep Yellow. This top-heavy structure means a handful of miners dominate performance, while the physical uranium trust component adds a direct link to spot uranium prices. URNM carries a net expense ratio of 0.75% and is structured as a thematic, long-only equity ETF. I also checked this using Tickeron’s AI Screener to see how the holdings compare within the sector.

URNM Price Performance Over the Last 30 Days and Quarter

URNM's recent price movement has been decisively negative. Over the last 30 days, the fund has fallen roughly 17%, sliding from a closing level near $43 to the mid-to-high $30s. The decline has been trend-driven rather than range-bound, punctuated by sharp single-session drops and only brief relief rallies.

The three-month picture is more severe. From a closing level near $55 in mid-August, and an intraday peak above $61 in late August, URNM has surrendered approximately 35%. This represents a pronounced reversal of the momentum that carried uranium equities higher through much of 2026, leaving the fund well below its summer highs.

What Drove the Recent 30-Day Slide in URNM

The recent slide reflects a combination of profit-taking and a shift in the near-term supply narrative. After an extended advance, uranium equities had priced in substantial upside, leaving them vulnerable to consolidation. Within the portfolio, heavyweight positions including Cameco, NexGen Energy, and Uranium Energy were among the primary contributors to the drawdown.

On the supply side, Kazatomprom — the world's largest uranium producer — reported first-half 2026 production up roughly 9% year over year and maintained full-year guidance in the 27,500 to 29,000 metric tonne range. Broader supply expansion and the prospect of a narrower near-term market deficit tempered the bullish momentum that had supported valuations. Physical uranium vehicles held within the fund, such as the Sprott Physical Uranium Trust, also transmitted spot-price softness directly into returns. The result was a steady, high-volatility decline rather than a single catalyst-driven shock.

Broader Drivers Behind the Quarterly Performance

The three-month trend reflects a broader rotation out of high-beta, commodity-linked equities. Uranium names had rallied sharply into late August on enthusiasm around nuclear energy demand, energy security, and structural supply deficits. As the spot and long-term uranium prices stabilized after reaching elevated levels, investors moved to lock in gains, and momentum reversed.

Mixed operational signals compounded the pullback. Cameco trimmed production guidance at its McArthur River operation, while simultaneously pointing to strong realized pricing and a robust contracting environment. Meanwhile, NexGen Energy advanced construction of its Rook I project, and Ur-Energy brought its Shirley Basin facility into commercial operation — longer-term positives that did little to offset near-term selling pressure. Institutional flows out of the sector amplified the decline across the fund's concentrated holdings. From what I see, this kind of rotation often follows periods of strong momentum in commodity themes.

URNM ETF Outlook and Key Factors to Monitor

The outlook for URNM hinges on the balance between a still-supportive long-term demand story and near-term supply dynamics. Key factors to monitor include the trajectory of spot and long-term uranium prices, utility contracting activity, and any further changes to Kazatomprom's production guidance. Cameco's realized pricing and McArthur River output, NexGen's Rook I construction progress, and the pace of Western reactor buildouts will also matter.

Macroeconomic conditions remain relevant. Interest-rate expectations and broader risk appetite influence how capital flows into high-beta commodity equities. Regulatory and policy developments around nuclear fuel security and enrichment capacity could serve as either catalysts or headwinds. Investors should weigh these structural drivers without assuming that recent momentum will persist in either direction. I’m watching this closely as supply updates continue to unfold.

Using Tickeron AI Tools in Sector Analysis

In my view, tools like Tickeron’s AI Screener can be helpful when evaluating thematic ETFs such as URNM. The platform allows screening across technical indicators, fundamentals, volatility metrics, and industry filters to surface comparable names or shifting conditions in the uranium space. I find it useful for cross-checking signals alongside traditional research when reviewing concentrated holdings like those in URNM.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: URNM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


URNM in -1.70% downward trend, sliding for three consecutive days on November 18, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where URNM declined for three days, in 273 of 302 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on URNM as a result. In 75 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The Moving Average Convergence Divergence Histogram (MACD) for URNM turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 40 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

The Aroon Indicator for URNM entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for URNM's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +9.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where URNM advanced for three days, in 301 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

URNM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the VettaFi Global Uranium Mining Index (the “Index”). The fund will, under normal circumstances, invest at least 80% of its total assets in securities of the index. The index consists of securities of both U.S. and foreign issuers, including securities of issuers located in emerging and frontier market countries. It is non-diversified.

Market Cap

The average market capitalization across the Sprott Uranium Miners ETF (URNM) ETF is 13.86B. The market cap for tickers in the group ranges from 1.23B to 6.04B. NXE holds the highest valuation in this group at 6.04B. The lowest valued company is CCO at 1.23B.

High and low price notable news

The average weekly price growth across all stocks in the Sprott Uranium Miners ETF (URNM) ETF was 9%. For the same ETF, the average monthly price growth was 17%, and the average quarterly price growth was 2%. EFR experienced the highest price growth at -0%, while PDN experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Sprott Uranium Miners ETF (URNM) ETF was 47%. For the same stocks of the ETF, the average monthly volume growth was 95% and the average quarterly volume growth was 39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 37
Price Growth Rating: 57
SMR Rating: 68
Profit Risk Rating: 75
Seasonality Score: 2 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.